Phase II Study of Adebrelimab and Bevacizumab With Cisplatin/Carboplatin in Triple-Negative Brea

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 04 Mar 2026. The item focuses on Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study). Review the original article for the full source wording and details.